MHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd)
Drug alert number: EL(26)A/09
Date issued: 23 February 2026
Sterling Pharmaceuticals Ltd and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution due to out of specification stability results.
DMRC reference number: DMRC-38487919
Company name: Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515)
Medicine Details
KidNaps (Melatonin) 1mg in 1ml Oral Solution
Licence: MS 32515
Active ingredient: melatonin
GTIN: 5060191450331
Affected Lot Batch Numbers:
| Batch No. | Expiry Date | Pack Size | First Distributed |
| 1743 | Mar 2026 | 200ml | 05/11/2024 |
| 1744 | Mar 2026 | 200ml | 12/11/2024 |
| 1787 | Jun 2026 | 200ml | 04/02/2025 |
| 1788 | Jun 2026 | 200ml | 21/02/2025 |
| 1852 | Dec 2026 | 200ml | 22/04/2025 |
| 1853 | Dec 2026 | 200ml | 27/06/2025 |
| 1955 | Jun 2027 | 200ml | 02/09/2025 |
| 1956 | Jun 2027 | 200ml | 05/11/2025 |
| 1992 | Sep 2027 | 200ml | 14/12/2025 |
| 1993 | Sep 2027 | 200ml | 05/02/2026 |
Background
Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515) and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution within expiry due to confirmed out of specification results from annual stability testing relating to product appearance and total impurities.
Advice for Healthcare Professionals
Stop supplying the above batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.
View the full alert here.
Advice for Patients
No action is required by patients, the recall is at the wholesaler and pharmacy level.
The recall is being undertaken out of an abundance of caution, patients using this medication may continue to do so. No adverse reactions have been reported from patients using this product. Patients or carers who have concerns about their medication should speak to their healthcare professional in the first instance.
Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme on https://yellowcard.mhra.gov.uk/
Additional information
For medical information enquiries on this product, email centralmedicalinformation@veritonpharma.com or telephone +44 (0)1932 690325.
For stock control enquiries, email orders@veritonpharma.com or telephone +44 (0)1932 690325.
The post MHRA Class 2 Medicines Recall: KidNaps (Melatonin) 1mg in 1ml Oral Solution (Sterling Pharmaceuticals Ltd) appeared first on Community Pharmacy England.